Modeling Multicellular Response to Nonuniform Distributions of Radioactivity: Differences in Cellular Response to Self-Dose and Cross-Dose

Abstract Howell, R. W. and Neti, P. V. S. V. Modeling Multicellular Response to Nonuniform Distributions of Radioactivity: Differences in Cellular Response to Self-Dose and Cross-Dose. Radiat. Res. 163, 216–221 (2005). Radiopharmaceuticals are distributed nonuniformly in tissue. While distributions of radioactivity often appear uniform at the organ level, in fact, microscopic examination reveals that only a fraction of the cells in tissue are labeled. Labeled cells and unlabeled cells often receive different absorbed doses depending on the extent of the nonuniformity and the characteristics of the emitted radiations. The labeled cells receive an absorbed dose from radioactivity within the cell (self-dose) as well as an absorbed dose from radioactivity in surrounding labeled cells (cross-dose). Unlabeled cells receive only a cross-dose. In recent communications, a multicellular cluster model was used to investigate the lethality of microscopic nonuniform distributions of 131I iododeoxyuridine (131IdU). For a given mean absorbed dose to the tissue, the dose response depended on the percentage of cells that were labeled. Specifically, when 1, 10 and 100% of the cells were labeled, a D37 of 6.4, 5.7 and 4.5 Gy, respectively, was observed. The reason for these differences was recently traced to differences in the cellular response to the self- and cross-doses delivered by 131IdU. Systematic isolation of the effects of self-dose resulted in a D37 of 1.2 ± 0.3 Gy. The cross-dose component yielded a D37 of 6.4 ± 0.5 Gy. In the present work, the overall survival of multicellular clusters containing 1, 10 and 100% labeled cells is modeled using a semi-empirical approach that uses the mean lethal self- and cross-doses and the fraction of cells labeled. There is excellent agreement between the theoretical model and the experimental data when the surviving fraction is greater than 1%. Therefore, when the distribution of 131I in tissue is nonuniform at the microscopic level, and the cellular response to self- and cross-doses differs, multicellular dosimetry can be used successfully to predict biological response, whereas the mean absorbed dose fails in this regard.

[1]  S. Adelstein,et al.  Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. , 1994, Radiation research.

[2]  D. W. Vinter,et al.  Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  A. Bishayee,et al.  Protection by DMSO against Cell Death Caused by Intracellularly Localized Iodine-125, Iodine-131 and Polonium-210 , 2000, Radiation research.

[4]  J. Little,et al.  Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. , 1998, Radiation research.

[5]  J. R. Reeves,et al.  Differential cytotoxicity of [123I]IUdR, [125I]IUdR and [131I]IUdR to human glioma cells in monolayer or spheroid culture: effect of proliferative heterogeneity and radiation cross-fire. , 1998, British Journal of Cancer.

[6]  J. Hendry,et al.  Quantitative Concepts and Dosimetry in Radiobiology , 1980 .

[7]  B. Wessels,et al.  The MIRD Perspective 1999 , 1999 .

[8]  I. Gardin,et al.  Dosimetry at the cellular level of Kupffer cells after technetium-99m-sulphur colloid injection. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Adelstein,et al.  Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium 99m-labeled microspheres and macroaggregates. , 1990, JAMA.

[10]  R. Sievert,et al.  Book Reviews : Recommendations of the International Commission on Radiological Protection (as amended 1959 and revised 1962). I.C.R.P. Publication 6. 70 pp. PERGAMON PRESS. Oxford, London and New York, 1964. £1 5s. 0d. [TB/54] , 1964 .

[11]  S. Strand,et al.  A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Roger W Howell,et al.  Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  A. Bishayee,et al.  Bystander effects caused by nonuniform distributions of DNA-incorporated (125)I. , 2002, Micron.

[14]  T. Budinger,et al.  MIRD cellular S. values : self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments , 1997 .

[15]  A. Bishayee,et al.  Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. , 1999, Radiation research.

[16]  J. Roeske,et al.  The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters. , 1999, Radiation research.

[17]  James A Scott Measurement of Dose Equivalents from External Photon and Electron Radiations ICRU Report 47. International Commission on Radiation Units and Measurements, Bethesda, 1992, $40.00 , 1993 .

[18]  A. Bishayee,et al.  Radiation protection by cysteamine against the lethal effects of intracellularly localized Auger electron, alpha- and beta-particle emitting radionuclides. , 2000, Acta oncologica.

[19]  S. Adelstein,et al.  Bystander effect produced by radiolabeled tumor cells in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Goddu,et al.  Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  K. Hofer,et al.  Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine. , 1971, Radiation research.

[22]  J. Humm,et al.  A model of cell inactivation by alpha-particle internal emitters. , 1993, Radiation research.

[23]  R. Sephton,et al.  A relationship between microdosimetric spectra and cell survival for high-LET irradiation. , 1991, International journal of radiation biology.

[24]  D. Le Guludec,et al.  Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of 99mTC, 123I, 111In, 67Ga and 201Tl , 1998, European Journal of Nuclear Medicine.

[25]  L. M. Cobb,et al.  Nonuniformity of tumor dose in radioimmunotherapy. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  S. Goddu,et al.  Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  R. Howell,et al.  When may a nonuniform distribution of 131I be considered uniform? An experimental basis for multicellular dosimetry. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  R. Howell,et al.  The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells. , 1991, Radiation research.

[29]  J. Little,et al.  Stress signaling from irradiated to non-irradiated cells. , 2004, Current cancer drug targets.